Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies

PURPOSE: To describe pooled efficacy and safety data from two phase 3 studies comparing brinzolamide 1%/brimonidine 0.2% fixed combination (BBFC) with its component medications, brinzolamide and brimonidine, in patients with open-angle glaucoma or ocular hypertension. METHODS: Data were pooled from...

Descripción completa

Detalles Bibliográficos
Autores principales: Realini, T, Nguyen, Q H, Katz, G, DuBiner, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709402/
https://www.ncbi.nlm.nih.gov/pubmed/23640612
http://dx.doi.org/10.1038/eye.2013.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709402/
https://www.ncbi.nlm.nih.gov/pubmed/23640612
http://dx.doi.org/10.1038/eye.2013.83

Ejemplares similares